Yichen Zhang

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersEconomic models and forecastingMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2025
Evolution of evidence on overall survival benefits of cancer drugs included on the national reimbursement drug list of China, 2005-2022: an observational study.

Yichen Zhang, Huangqianyu Li, Jinyu Chen

|Aug 21, 2025
Associations between clinical benefits of cancer drugs and incremental quality-adjusted life years used in reimbursement decisions in Australia, Canada, England and China: an observational study.

Jinyu Chen, Kexin Han, Yichen Zhang

|Dec 12, 2023
Use of suboptimal control arms in randomized clinical trials of investigational cancer drugs in China, 2016-2021: An observational study.

Yichen Zhang, Dingyi Chen, Siyuan Cheng

|Sep 18, 2021
Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States.

Yichen Zhang, Anita Katharina Wagner, Haoxin Du

|Jan 09, 2020
Differences in reimbursement listing of anticancer therapies in China: an observational study.

Xiaodong Guan, Yichen Zhang, Haishaerjiang Wushouer

Pageof 1

Frequent Collaborators

4 joint publications

Xiaodong Guan

3 joint publications

Luwen Shi

1 joint publications

Anita Katharina Wagner

1 joint publications

Haoxin Du